SCHEMBL667664

SCHEMBL667664

CCCCCCCCCCCCCCCCCC(=O)OI.[CaH2]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.59
LMNA P02545 2/20 0.55
MAPT P10636 2/20 0.55
PAM P19021 2/20 0.53
CES2 O00748 3/20 0.52
CES1 P23141 3/20 0.52
MAPK1 P28482 1/20 0.52
PPARG P37231 6/20 0.50
PPARD Q03181 6/20 0.50
PPARA Q07869 6/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 4/20 0.50
GPR84 Q9NQS5 4/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
PTPN1 P18031 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14421969 0.98 DGKA (0.61) DGKALMNAMAPTPAMCES2
SCHEMBL2184258 0.98 DGKA (0.61) DGKALMNAMAPTPAMCES2
SCHEMBL2181366 0.98 DGKA (0.61) DGKALMNAMAPTPAMCES2
SCHEMBL1401720 0.98 DGKA (0.61) DGKALMNAMAPTPAMCES2
SCHEMBL2182481 0.98 DGKA (0.61) DGKALMNAMAPTPAMCES2
SCHEMBL27469025 0.95 DGKA (0.59) DGKALMNAMAPTPAMCES2
SCHEMBL5139559 0.95
SCHEMBL19358157 0.93 DGKA (0.57) DGKALMNAMAPTPAMCES2
SCHEMBL5050853 0.88
SCHEMBL2234093 0.86 TERT (0.61) LMNAMAPTPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021054927-A2 GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS SOUTH DAKOTA BOARD OF REGENTS (US) 2021-03-25 WO claimed
US-20200048305-A1 GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS SOUTH DAKOTA BOARD OF REGENTS (US) 2020-02-13 US claimed
US-9622969-B2 Polymer conjugated protein micelles SOUTH DAKOTA STATE UNIV (US) 2017-04-18 US claimed
US-20140370110-A1 POLYMER CONJUGATED PROTEIN MICELLES SOUTH DAKOTA STATE UNIVERSITY (US) 2014-12-18 US claimed
EP-2214716-B1 HYDROXYAPATITE-TARGETING MULTIARM POLYMERS AND CONJUGATES MADE THEREFROM NEKTAR THERAPEUTICS (US) 2021-11-17 EP disclosed
WO-2021054927-A2 GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS SOUTH DAKOTA BOARD OF REGENTS (US) 2021-03-25 WO disclosed
US-10668161-B2 Therapeutic hyperbranched polyglycerol encapsulated biomolecules THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-06-02 US disclosed
US-20200048305-A1 GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS SOUTH DAKOTA BOARD OF REGENTS (US) 2020-02-13 US disclosed
CN-109562137-A Methods and compositions for treating conditions associated with abnormal inflammatory responses 第波生物公司 2019-04-02 CN disclosed
US-20190021999-A1 EXTREMELY SMALL NANOPARTICLES OF DEGRADABLE POLYMERS PHOSPHOREX, INC. 2019-01-24 US disclosed
EP-3337455-A1 EXTREMELY SMALL NANOPARTICLES OF DEGRADABLE POLYMERS Phosphorex Inc. (US) 2018-06-27 EP disclosed
EP-2319542-B1 Segmented degradable polymers and conjugates made therefrom NEKTAR THERAPEUTICS (US) 2018-03-21 EP disclosed
US-6419017-B1 REACTING GROUP 2A COMPOUND, FATTY ACID; PRECIPITATION BJ SERVICES COMPANY 2002-07-16 US disclosed
US-6365146-B1 POLYAMIDEESTER COPOLYMER RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-04-02 US disclosed
WO-2002025055-A1 METHOD OF PREVENTING GAS BREAKTHROUGH IN AN OIL BEARING FORMATION BJ SERVICES COMPANY (US) 2002-03-28 WO disclosed
US-20020035217-A1 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-03-21 US disclosed
EP-1176983-A2 HYPERBRANCHED POLYMERIC MICELLES FOR ENCAPSULATION AND DELIVERY OF HYDROPHOBIC MOLECULES RUTGERS, THE STATE UNIVERSITY (US) 2002-02-06 EP disclosed
US-6328988-B1 DRUGS AND COSMETICS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2001-12-11 US disclosed
CN-1291898-A Remedies for corneal epithelium disturbance WAKAMOTO PHARMA CO LTD (JP) 2001-04-18 CN disclosed
WO-2000065024-A2 HYPERBRANCHED POLYMERIC MICELLES FOR ENCAPSULATION AND DELIVERY OF HYDROPHOBIC MOLECULES RUTGERS, THE STATE UNIVERSITY (US) 2000-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10668161-B2 Therapeutic hyperbranched polyglycerol encapsulated biomolecules FABP2, SI, PNLIP DGKA 950/4885LMNA 2893/4885MAPT 2555/4885
US-20200048305-A1 GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS GSTK1, GSTO1, GSTM2 DGKA 126/4885LMNA 3751/4885MAPT 1050/4885
US-20140370110-A1 POLYMER CONJUGATED PROTEIN MICELLES MTDH, PSMG3, GHITM DGKA 3620/4885LMNA 1032/4885MAPT 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.